| Geraldine Whitaker, LPN | |
|
110 W Walker Ave, Asheboro, NC 27203-6760 | |
| (336) 633-7000 | |
| (336) 625-3817 |
| Full Name | Geraldine Whitaker |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 110 W Walker Ave, Asheboro, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932613049 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 029066 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Geraldine Whitaker, LPN 284 Executive Park Dr Ste 100, Concord, NC 28025-1833 Ph: (704) 939-1100 | Geraldine Whitaker, LPN 110 W Walker Ave, Asheboro, NC 27203-6760 Ph: (336) 633-7000 |
News Archive
About three in ten patients using letrozole (Femara), a common medication for treating breast cancer, are likely taking the medication to treat infertility, according to a new study presented today at the Academy of Managed Care Pharmacy's 22nd Annual Meeting in San Diego by Prime Therapeutics, a thought leader in pharmacy benefit management.
A new study led by City of Hope researchers has found that regular use of low-dose aspirin (81mg) reduces breast cancer risk in women. Led by Leslie Bernstein, the team found that women who took the low-dose aspirin, also known as "baby" aspirin, at least three times per week had an overall 16% reduced risk of developing breast cancer.
Research into inflammatory bowel disease (IBD) led by UCD Conway Institute scientists with national and international collaborators has identified a key regulator involved in maintaining the functional integrity of the gut lining. The findings, published recently in the scientific journal, Gastroenterology, provide information that may be important in developing a new therapeutic approach to the treatment of the disease.
Using a new, powerful method for rapidly screening molecules associated with disease, proteomics expert Joshua LaBaer and colleagues from the Biodesign Institute at Arizona State University have identified a broad panel of 28 early predictors, or biomarkers, that may one day aid in the early diagnosis of breast cancer.
Two young researchers working at the MIPT Laboratory of Nanooptics and Plasmonics, Dmitry Fedyanin and Yury Stebunov, have developed an ultracompact highly sensitive nanomechanical sensor for analyzing the chemical composition of substances and detecting biological objects, such as viral disease markers, which appear when the immune system responds to incurable or hard-to-cure diseases, including HIV, hepatitis, herpes, and many others.
› Verified 2 days ago
Lafawn C Dowdell, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 341 N Fayetteville St, Asheboro, NC 27203 Phone: 833-510-4357 | |
Miss Amber Desiree Goff, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 341 N Fayetteville St, Asheboro, NC 27203 Phone: 833-510-4357 Fax: 866-460-2997 | |
Sherri Darnice Hauser, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 110 W Walker Ave, Asheboro, NC 27203 Phone: 336-633-7000 | |
Laura Cannon Maness, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 110 W Walker Ave, Asheboro, NC 27203 Phone: 336-633-7000 |